While they can all cause liver disease, they differ in important ways, including modes of transmission, severity of the illness, geographical distribution, and prevention methods.
Africa CDC also acknowledged the efforts of key stakeholders and communities involved in the hepatitis response and pledged continued support for Nigeria’s health agenda.
——Some Hepatitis Facts—–
How does someone get hepatitis?
You may get hepatitis A when you eat or drink something contaminated with infected stool. You may also get the infection through close contact with a person who has hepatitis A. The virus can live on surfaces for a few months. The virus does not spread through casual contact or by sneezing or coughing.2 Jul 2024
What are the main 6 symptoms of hepatitis?
· Dark urine or clay-colored stools.
· Feeling tired.
· Fever.
· Joint pain.
· Loss of appetite.
· Nausea, stomach pain, throwing up.
· Yellow skin or eyes (jaundice)
Which hepatitis is not curable?
Chronic hepatitis B is generally not curable. While there are treatments to manage the infection and prevent liver damage, there is no cure for chronic hepatitis B. Hepatitis C, on the other hand, is curable with new treatments.
Most adults who contract hepatitis B will recover on their own (acute infection). However, a significant portion (especially infants and children) develop chronic hepatitis B, which is a long-term infection with no cure. While there’s no cure, treatments can help manage the infection and reduce the risk of liver damage.
How do I know if I’ve got hepatitis?
Long-term (chronic) hepatitis also may not have any obvious symptoms until the liver stops working properly (liver failure) and may only be picked up during blood tests. In the later stages it can cause jaundice, swelling in the legs, ankles and feet, confusion, and blood in your stools or vomit.
How do you avoid getting hepatitis?
Ensuring good hygiene and avoiding contact with contaminated objects or bodily fluids can protect against infection by any of the hepatitis viruses. Hepatitis A is spread through close contact with an infected person or contact with water and food contaminated by stool, which may occur in places with poor sanitation.
How do you flush out hepatitis?
It is very important people who know they have acute Hepatitis B get regular sleep if tired and avoid alcohol and antibiotics as both can make the Virus lasting and chronic. Diet should be mild avoiding fried and fatty foods and far less red meat. Water is also important to help flush the virus out.
What are the first signs of a bad liver?
The first signs of a bad liver can include jaundice (yellowing of the skin and eyes), abdominal pain and swelling, swelling in the legs and ankles, itchy skin, dark urine, pale stool, constant tiredness, and nausea or vomiting. Additionally, a general sense of un-wellness (malaise), disorientation, sleepiness, and a musty or sweet odor in the breath can also be early indicators.
———Nigeria, 9 Others Account For 70% Global Hepatitis B deaths —WHO—–
The World Health Organization (WHO) says Nigeria and nine other countries in Africa and Asia accounted for about 70 per cent of the global Hepatitis B related deaths in 2024.
WHO, in its newly published ‘2026 Global Hepatitis Report, on Tuesday, also said Nigeria and nine other countries accounted for 58 per cent of global hepatitis cases.
“Ten countries in Asia and Africa – Bangladesh, China, Ethiopia, Ghana, India, Indonesia, Nigeria, the Philippines, South Africa and Vietnam – accounted for nearly 70 per cent of hepatitis B related deaths worldwide that year.”
“In 2024, 10 countries accounted for 58 per cent of global cases: China, India, Indonesia, Japan, Nigeria, Pakistan, Russia, South Africa, the United States and Vietnam,” WHO said.
Hepatitis B is a viral infection that attacks the liver.
It can be spread through contact with infected body fluids such as blood, saliva, vaginal fluids and semen, or passed from mother to baby.
The disease can be acute or chronic, with chronic infection raising risk of death from cirrhosis and liver cancer.
Hepatitis C is an inflammation of the liver caused by a virus of the same name.
Transmission is spread through exposure to infected blood from unsafe injections, such as sharing needles and syringes or unscreened blood transfusions.
WHO estimates 287 million people or roughly three per cent of the global population were living with chronic Hepatitis B or C infection in 2024.
The new report says the WHO African Region accounted for 68 per cent of new hepatitis B infections.
It also says only 17 per cent of newborns there received a birth-dose vaccination.
Although 240 million people were living with chronic Hepatitis B in 2024, fewer than five per cent were receiving treatment.
The report further says only 20 per cent of people with Hepatitis C have been treated since new effective treatment became available in 2015.
The global health body regretted that limited access to prevention and care continues to drive mortality.
“In 2024, roughly 1.1 million people died from Hepatitis B and 240,000 from Hepatitis C, mainly due to liver cirrhosis and liver cancer,” the report found.
These infections claimed 1.34 million lives in 2024.
The world health agency also said transmission continues at a rate of some 1.8 million infections annually or more than 4,900 cases every day.
However, WHO says countries are making measurable progress in combatting viral hepatitis.
WHO also says new Hepatitis B infections have declined by 32 per cent while Hepatitis C-related deaths have dropped by 12 per cent.
Hepatitis B prevalence among children under five has also fallen to 0.6 per cent, with 85 countries achieving or surpassing the 2030 target of reducing prevalence to 0.1 per cent.
WHO highlights significant gains made in the fight against Hepatitis B and C, which together account for 95 per cent of all hepatitis-related deaths worldwide.
WHO said these advances reflect sustained and coordinated international action towards viral hepatitis elimination targets adopted at the 2016 World Health Assembly but current rates are insufficient to meet all 2030 elimination targets.
WHO Director-General Tedros Ghebreyesus said countries have shown that “eliminating hepatitis is not a pipedream,” but efforts must accelerate.
“Many people remain undiagnosed and untreated due to stigma, weak health systems and inequitable access to care,” Tedros said.
“While we have the tools to eliminate hepatitis as a public health threat, urgent scale-up of prevention, diagnosis and treatment is needed if the world is to meet the 2030 targets.”
In spite of these challenges, WHO pointed to the highly effective tools that are already available in the fight against the disease.
The Hepatitis B vaccine is more than 95 per cent effective against both acute and chronic infections, while long-term antiviral treatment can help manage chronic infection and prevent severe liver disease.
At the same time, short-course therapy for Hepatitis C, lasting 8 to 12 weeks, can cure more than 95 per cent of cases.
